Terry White Chemists Meloxicam

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS MELOXICAM TABLETS Contains the active ingredient, meloxicam Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about meloxicam. It does not contain all the available information. It does not take the […]

Read more

Feldene and Feldene-D

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. FELDENE® CAPSULES; FELDENE-D® DISPERSIBLE TABLETS Piroxicam (pir-oks-i-kam) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about FELDENE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

Read more

Brufen Tablets

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BRUFEN® Ibuprofen Consumer Medicine Information PLEASE READ THIS INFORMATION CAREFULLY What is in this leaflet This leaflet answers some common questions about BRUFEN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

Read more

Craig Revel Horwood health: ‘It was getting worse’ Strictly star’s health battle

Craig Revel Horwood, 54, is an Australian-British dancer, choreographer, conductor, author, theatre director and television personality. His commitment to dancing and theatrical performance is on full display every Saturday night as a judge on Strictly Come Dancing. Speaking to the Express.co.uk last year, the Strictly judge revealed he has a chronic health condition. He first experienced symptoms during a theatre […]

Read more

New hope in the treatment of arthritis

World largest genetic study of osteoarthritis provide new approaches to treatment In the world’s largest genetic study of osteoarthritis changes in the genome have been discovered, which are associated with the disease. In addition, the researchers found approaches to partially existing medications for osteoarthritis. Approximately five million Germans are affected by the disease Osteoarthritis is the most widespread musculoskeletal disease […]

Read more

Joint mobilization plus exercise beneficial for knee osteoarthritis

(HealthDay)—Patellar mobilization therapy (PMT) plus exercise has the potential to reduce pain and improve function and quality of life for patients with knee osteoarthritis, according to a phase 2 study published Nov. 12 in the Annals of Family Medicine. Regina Wing Shan Sit, M.B.B.S., from the Chinese University of Hong Kong, and colleagues randomly assigned 208 primary care patients with […]

Read more

Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients

NEW YORK & INDIANAPOLIS–(BUSINESS WIRE October 23, 2018 )–Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients with osteoarthritis (OA) pain treated for 16 weeks. The study met all three co-primary efficacy endpoints, demonstrating […]

Read more